Germany – Social work and related services – Sozialarbeit in Schulen (SiS)

Wetteraukreis · Germany government procurement

Closed May 23, 2024. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The success and benefits of social work in schools have been demonstrated in the past through various funding instruments of the Wetterau district. Based on this experience, the Wetterau district embarked on a new path in the 2017/18 school year, initiating the comprehensive expansion of social work in schools, which was completed in the 2020/21 school year. Twelve school clusters were formed in the Wetterau district according to social planning criteria, each encompassing at least one secondary school and the surrounding primary schools. The current contract aims to regulate the continuation of social work in schools within these clusters (grades 8-12). As a public youth welfare provider, the Wetterau district supports the educational work of its schools by employing social work professionals and methods. This task is to be carried out by recognized independent youth welfare organizations in accordance with Section 75 of the German Social Code, Book VIII (SGB VIII), within the framework of the contract to be awarded. The primary focus of social work in schools is direct work with students. It collaborates with other stakeholders within and outside the school system, taking a situation-specific and case-independent approach. This results in complementary goals and tasks that are closely interrelated. By expanding social work in schools, the Wetterau district is fulfilling its responsibility for creating favorable conditions for the education and upbringing of young people within the district. Due to societal changes, the evolving ways children and adolescents grow up, increasing ethnic and socio-cultural diversity, and growing mobility, youth services, schools, and municipalities nationwide face the necessity of understanding education and upbringing as a shared responsibility. Greater equality of opportunity and educational equity are the common goals, while the pooling of resources and the utilization of diverse skills are the shared path to ensuring the...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyWetteraukreis
CountryGermany
CategoryPharmaceuticals
CPV85300000
PublishedApril 19, 2024
Procurement stageActive solicitation
ClosedMay 23, 2024
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 09, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lipegfilgrastim, (OBO) ATC L03AA14 für die Zeit 01.02.2025 - 31.01.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Haloperidol (ausschließlich Injektionslösung), ATC N05AD01 für die Zeit 01.12.2025 - 30.11.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dimethylfumarat (ausschl 240mg, N3), ATC L04AX07 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerung 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschl. z. intramuskulären Injektion), ATC L03AB07 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriparatid, ATC H05AA02 für die Zeit 01.02.2026 - 31.01.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Paliperidon (ausschließlich 3-Monats-Depot), ATC N05AX13 für die Zeit 01.01.2026 - 31.12.2027

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.